|
Volumn 7, Issue 4, 2002, Pages 170-173
|
Persistent pain prevalence and medical management;La prévalence et la prise en charge médicale de la douler persistante
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANALGESIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIINFLAMMATORY AGENT;
ANTIMIGRAINE AGENT;
CODEINE;
CORTICOSTEROID DERIVATIVE;
CYCLOOXYGENASE 2 INHIBITOR;
MORPHINE;
MUSCLE RELAXANT AGENT;
NARCOTIC ANALGESIC AGENT;
NON PRESCRIPTION DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE DERIVATIVE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ACUPUNCTURE;
AGE;
ANALGESIA;
BEHAVIOR THERAPY;
BODY REGIONS;
CANADA;
CHRONIC PAIN;
COMORBIDITY;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG RESPONSE;
EDITORIAL;
EPIDEMIOLOGICAL DATA;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HEALTH SURVEY;
HUMAN;
KINESIOTHERAPY;
MASSAGE;
MEDICAL ASSESSMENT;
METHODOLOGY;
NEURALGIA;
PAIN ASSESSMENT;
PAIN CLINIC;
PHYSIOTHERAPY;
PRESCRIPTION;
PREVALENCE;
QUALITY OF LIFE;
RELAXATION TRAINING;
RISK BENEFIT ANALYSIS;
TRANSCUTANEOUS NERVE STIMULATION;
TREATMENT FAILURE;
|
EID: 0036991152
PISSN: 12036765
EISSN: None
Source Type: Journal
DOI: 10.1155/2002/469716 Document Type: Editorial |
Times cited : (1)
|
References (3)
|